Literature DB >> 23459489

Detection of linezolid-resistant Staphylococcus aureus with 23S rRNA and novel L4 riboprotein mutations in a cystic fibrosis patient in Spain.

Federico Román, Carolina Roldán, Pilar Trincado, Carmen Ballesteros, Concepción Carazo, Ana Vindel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23459489      PMCID: PMC3632889          DOI: 10.1128/AAC.00208-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.

Authors:  Rebecca A Keel; Andre Schaeftlein; Charlotte Kloft; J Samuel Pope; R Frederic Knauft; Marianne Muhlebach; David P Nicolau; Joseph L Kuti
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

2.  Mutation of L4 ribosomal protein conferring unusual macrolide resistance in two independent clinical isolates of Staphylococcus aureus.

Authors:  Anne-Laure Prunier; Hiep N'Guyen Trong; Didier Tande; Christine Segond; Roland Leclercq
Journal:  Microb Drug Resist       Date:  2005       Impact factor: 3.431

3.  Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates.

Authors:  Corinna Kehrenberg; Stefan Schwarz
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

4.  Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio.

Authors:  Andrea Endimiani; Martha Blackford; Elliot C Dasenbrook; Michael D Reed; Saralee Bajaksouszian; Andrea M Hujer; Susan D Rudin; Kristine M Hujer; Vincent Perreten; Louis B Rice; Michael R Jacobs; Michael W Konstan; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

5.  Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy.

Authors:  Rodrigo E Mendes; Lalitagauri M Deshpande; David J Farrell; Teresa Spanu; Giovanni Fadda; Ronald N Jones
Journal:  J Antimicrob Chemother       Date:  2010-09-14       Impact factor: 5.790

6.  Linezolid surveillance results for the United States: LEADER surveillance program 2011.

Authors:  Robert K Flamm; Rodrigo E Mendes; James E Ross; Helio S Sader; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

7.  Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.

Authors:  Satish K Pillai; George Sakoulas; Christine Wennersten; George M Eliopoulos; Robert C Moellering; Mary Jane Ferraro; Howard S Gold
Journal:  J Infect Dis       Date:  2002-11-04       Impact factor: 5.226

8.  Methicillin-resistant Staphylococcus aureus in Spain: molecular epidemiology and utility of different typing methods.

Authors:  Ana Vindel; Oscar Cuevas; Emilia Cercenado; Carmen Marcos; Verónica Bautista; Carol Castellares; Pilar Trincado; Teresa Boquete; Maria Pérez-Vázquez; Mercedes Marín; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

Review 9.  The emerging problem of linezolid-resistant Staphylococcus.

Authors:  Bing Gu; Theodoros Kelesidis; Sotirios Tsiodras; Janet Hindler; Romney M Humphries
Journal:  J Antimicrob Chemother       Date:  2012-09-04       Impact factor: 5.758

  9 in total
  8 in total

1.  Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a Simulated Pharmacodynamic/Pharmacokinetic Model.

Authors:  Razieh Kebriaei; Seth A Rice; Kyle C Stamper; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Structural insights into species-specific features of the ribosome from the pathogen Staphylococcus aureus.

Authors:  Zohar Eyal; Donna Matzov; Miri Krupkin; Itai Wekselman; Susanne Paukner; Ella Zimmerman; Haim Rozenberg; Anat Bashan; Ada Yonath
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-13       Impact factor: 11.205

3.  Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis.

Authors:  Juan de Dios Caballero; María Dolores Pastor; Ana Vindel; Luis Máiz; Genoveva Yagüe; Carme Salvador; Marta Cobo; María-Isabel Morosini; Rosa del Campo; Rafael Cantón
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

4.  In-Host Emergence of Linezolid Resistance in a Complex Pattern of Toxic Shock Syndrome Toxin-1-Positive Methicillin-Resistant Staphylococcus aureus Colonization in Siblings with Cystic Fibrosis.

Authors:  Agathe Boudet; Alexandre Jay; Catherine Dunyach-Remy; Raphaël Chiron; Jean-Philippe Lavigne; Hélène Marchandin
Journal:  Toxins (Basel)       Date:  2021-04-28       Impact factor: 4.546

5.  Mechanisms of linezolid resistance in staphylococci and enterococci isolated from two teaching hospitals in Shanghai, China.

Authors:  Yueru Tian; Tianming Li; Yuanjun Zhu; Bei Wang; Xue Zou; Min Li
Journal:  BMC Microbiol       Date:  2014-11-25       Impact factor: 3.605

6.  In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.

Authors:  Sang-Hun Oh; Josep Kim; Sung-Yoon Baek; Sang-Eun Chae; Hee-Soo Park; Young-Lag Cho; Jin-Hwan Kwak
Journal:  Molecules       Date:  2017-03-03       Impact factor: 4.411

7.  Synthesis of covalent bonding MWCNT-oligoethylene linezolid conjugates and their antibacterial activity against bacterial strains.

Authors:  José A Alatorre-Barajas; Eleazar Alcántar-Zavala; M Graciela Gil-Rivas; Edgar Estrada-Zavala; Adrián Ochoa-Terán; Y Gochi-Ponce; Julio Montes-Ávila; Alberto Cabrera; Balter Trujillo-Navarrete; Yazmin Yorely Rivera-Lugo; Gabriel Alonso-Núñez; Edgar A Reynoso-Soto; J L Medina-Franco
Journal:  RSC Adv       Date:  2021-08-31       Impact factor: 4.036

8.  Phenotypic and genotypic characterization of linezolid-resistant Enterococcus faecium from the USA and Pakistan.

Authors:  Kate E Wardenburg; Robert F Potter; Alaric W D'Souza; Tahir Hussain; Meghan A Wallace; Saadia Andleeb; Carey-Ann D Burnham; Gautam Dantas
Journal:  J Antimicrob Chemother       Date:  2019-12-01       Impact factor: 5.790

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.